Pharmacokinetic interaction between atorvastatin and fixed-dose combination of sofosbuvir/ledipasvir in healthy male Egyptian volunteers
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00228-021-03130-z.pdf
Reference54 articles.
1. Abd-Elsalam S, Badawi R, Elnawasany S, Yousef M, Mansour L, Hawash N, Elkhouly RA, Soliman S, Selim A, Kobtan A (2019) Sofosbuvir, pegylated interferon and ribavirin in the treatment of an Egyptian cohort with hepatitis C virus infection in real-life clinical practice. Infect Disord Drug Targets (formerly current drug targets-infectious disorders) 19(2):179–184. https://doi.org/10.2174/1871526518666180912121835
2. Ahmed OA, Kaisar HH, Badawi R, Hawash N, Samir H, Shabana SS, Fouad MHA, Rizk FH, Khodeir SA, Abd-Elsalam S (2018) Efficacy and safety of sofosbuvir–ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection. Infect Drug Resist 11:295–298. https://doi.org/10.2147/IDR.S153060
3. Cha A, Budovich A (2014) Sofosbuvir: a new oral once-daily agent for the treatment of hepatitis C virus infection. Pharm Ther 39(5):345–352
4. Kim CW, Chang K-M (2013) Hepatitis C virus: virology and life cycle. Clin Mol Hepatol 19(1):17–25. https://doi.org/10.3350/cmh.2013.19.1.17
5. Elgharably A, Gomaa AI, Crossey MM, Norsworthy PJ, Waked I, Taylor-Robinson SD (2017) Hepatitis C in Egypt–past, present, and future. Int J Gen Med 10:1–6. https://doi.org/10.2147/IJGM.S119301
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Major Genetic Drivers of Statin Treatment Response in African Populations and Pharmacogenetics of Dyslipidemia Through a One Health Lens;OMICS: A Journal of Integrative Biology;2023-11-14
2. Simple HPLC-UV Method for Piperacillin/Tazobactam Assay in Human Plasma;Antibiotics;2023-02-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3